Heart failure & cardiomyopathies

Determinants of Ejection Fraction Improvement in Heart Failure Patients with Reduced Ejection Fraction

ESC Heart FailPublished Secondary analysis of the REDEAL heart failure (HF) trial

Primary result · CV events (primary composite)Result — go to the resultHazard ratio 0.519 95% CI 0.381–0.708

Authors' conclusion

Improvement in EF is independently related to the longer survival and lower CV related mortality and hospitalization rate of HFrEF. Elevated baseline NT-proBNP is identified as the strongest prognostic factor associated with increased CV events risk in HFrEF patients both with and without improved EF, regardless of age, sex, duration of HF, and other clinical risk factors.

Study context

Population
Consecutive patients with chronic HFrEF (ejection fraction (EF) < 40%) hospitalized July 2009–December 2017, with baseline and follow-up echocardiography (interval ≥12 months)
Participants
573 patients
Comparison
Improved EF vs non-improved EF
Primary endpoint
Composite of:
  • CV death
  • CV hospitalization
  • Appropriate ICD therapy for ventricular arrhythmia
Methodological detailsretrospective
  • Retrospective

Primary result

CV events (primary composite)

Hazard ratio

0.519

95% CI 0.381–0.708

P < 0.001

By group

iEFvs niEF
HR 0.519 (95% CI 0.381–0.708); P < 0.001

As reported in the abstract

Further findings

OutcomeiEFniEFEstimateP value
All-cause mortalityAdjusted22.1%31.1%HR 0.674 (95% CI 0.469–0.968)P = 0.019
CV mortalityAdjusted8.9%16.1%HR 0.539 (95% CI 0.317–0.916)P = 0.015
Independent determinants of iEFHF duration >4 yearsvs ≤4 yearsOR 0.477 (95% CI 0.305–0.745)
Independent determinants of iEFCADvs no CADOR 0.583 (95% CI 0.396–0.858)
Independent determinants of iEFICDvs no ICDOR 0.341 (95% CI 0.228–0.511)

Proportion with EF improvement · median 17 months

EF improved
37.2%

Risk factors for cardiovascular (CV) events in improved EF (iEF) (subgroup)

Hypertension HR = 2.452
P = 0.032
NT-proBNP >1153 pg/mL HR = 4.372
P < 0.001

Risk factors for CV events in non-improved EF (niEF) (subgroup)

Implantable cardioverter-defibrillator (ICD) implantation HR = 1.533
P = 0.011
Elevated NT-proBNP HR = 1.626
P = 0.018
Increased left atrial volume index HR = 1.461
P = 0.021
Reduced lateral mitral annular plane systolic excursion HR = 1.478
P = 0.025
Reduced tricuspid plane systolic excursion HR = 1.491
P = 0.039

Original publication

Determinants of Ejection Fraction Improvement in Heart Failure Patients with Reduced Ejection Fraction. ESC Heart Fail. Published 2 February 2023. doi:10.1002/ehf2.14303

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.